HC Wainwright & Co. Reiterates Puma Biotechnology (PBYI) Buy Recommendation

Fintel reports that on September 20, 2023, HC Wainwright & Co. reiterated coverage of Puma Biotechnology (NASDAQ:PBYI) with a Buy recommendation. Analyst Price Forecast Suggests 65.92% Upside 


Leave a Reply

Your email address will not be published. Required fields are marked *

Search this website